Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Dianthus Therapeutics, Inc. /DE/ from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2025 was $321,000, a 26% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $321,000 -$110,000 -26% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $342,000 +$325,000 +1912% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $370,000 +$343,000 +1270% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $398,000 +$359,000 +921% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $431,000 +$377,000 +698% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $17,000 -$54,000 -76% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $27,000 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $39,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $54,000 -$62,000 -53% 31 Dec 2023 10-K 21 Mar 2024 2023 FY
Q3 2023 $71,000 -$10,701,000 -99% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q4 2022 $116,000 31 Dec 2022 8-K 21 Dec 2023
Q3 2022 $10,772,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $11,634,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.